# Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

> **NCT02691611** · — · COMPLETED · sponsor: **National Jewish Health** · enrollment: 39 (actual)

## Conditions studied

- Alpha 1-Antitrypsin Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02691611
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-11
- **Final completion:** 2020-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02691611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02691611, "Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02691611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*